Muneeb Ullah | Nanobiotechnology | Best Paper Award

Published on by Nano Technology

Mr. Muneeb Ullah | Nanobiotechnology | Best Paper Award

PhD Student | Pusan National University | South Korea

Mr. Muneeb Ullah is an accomplished nanomedicine researcher specializing in pharmaceutical nanotechnology, drug delivery systems, and biomaterials for therapeutic applications. His research primarily focuses on the synthesis and characterization of nanoparticles for wound healing, colorectal cancer, diabetic wound treatment, and inflammatory bowel diseases. He has published 38 scientific documents with 504 citations and an h-index of 11, reflecting strong and consistent contributions to high-impact biomedical research. Mr. Muneeb Ullah has authored numerous peer-reviewed journal papers and book chapters in leading outlets such as Chemical Engineering Journal, Small, Carbohydrate Polymer Technologies & Applications, European Polymer Journal, Journal of Pharmaceutical Investigation, and Current Problems in Cardiology. His works have collectively accumulated an impressive total impact factor exceeding 120. His notable contributions include advancements in nanoparticle-based therapeutics, 3D and 4D bioprinting, nanocarbon-based biomedical materials, and smart wound-healing systems. He has also co-authored multiple academic books and chapters published by CRC Press and Academic Press, covering topics such as fungal biotechnology, gastrointestinal inflammation, carbon dots, cancer nanomedicine, and nanotechnology in wound healing. His interdisciplinary collaborations have led to innovations in biofilm-associated therapies, tissue engineering, and targeted drug delivery systems. Recognized as a Best Researcher Award recipient in 2024 and 2025, Mr. Muneeb Ullah’s scholarly impact extends to editorial and reviewer services for international journals. His ongoing projects explore novel nanocluster adhesives, biopolymer-based nanostructures, and tumor-selective delivery mechanisms. Through his pioneering R&D initiatives, Mr. Muneeb Ullah continues to advance the frontiers of nanomedicine, combining pharmaceutical technology with molecular innovation to address complex biomedical challenges globally.

Profiles: Scopus | ResearchGate | Sci Profiles | Scholar GPS

Featured Publications

1. Safdar, M., Ullah, M., Hamayun, S., Wahab, A., Khan, S. U., Abdikakhorovich, S. A., Haq, Z. U., Mehreen, A., Naeem, M., Mustopa, A. Z., & Hasan, N. (2024). Microbiome miracles and their pioneering advances and future frontiers in cardiovascular disease. Current Problems in Cardiology, 49(9), 102686. https://doi.org/10.1016/j.cpcardiol.2024.102686

2. Khan, M. A., Khan, N., Ullah, M., Hamayun, S., Makhmudov, N. I., Mbbs, R., Safdar, M., Bibi, A., Wahab, A., Naeem, M., & Hasan, N. (2024). 3D printing technology and its revolutionary role in stent implementation in cardiovascular disease. Current Problems in Cardiology, 49(6), 102568. https://doi.org/10.1016/j.cpcardiol.2024.102568

3. Khan, S. U., Ullah, M., Saeed, S., Saleh, E. A. M., Kassem, A. F., Arbi, F. M., Wahab, A., Rehman, M., ur Rehman, K., Khan, D., … & Lu, K. (2024). Nanotherapeutic approaches for transdermal drug delivery systems and their biomedical applications. European Polymer Journal, 207, 112819. https://doi.org/10.1016/j.eurpolymj.2024.112819

4. Khan, S. U., Huang, Y., Ali, H., Ali, I., Ahmad, S., Khan, S. U., Hussain, T., Ullah, M., & Lu, K. (2024). Single-cell RNA sequencing (scRNA-seq): Advances and challenges for cardiovascular diseases (CVDs). Current Problems in Cardiology, 49(2), 102202. https://doi.org/10.1016/j.cpcardiol.2023.102202

5. Zeb, F., Mehreen, A., Naqeeb, H., Ullah, M., Waleed, A., Awan, U. A., Haider, A., & Naeem, M. (2024). Nutrition and dietary intervention in cancer: Gaps, challenges, and future perspectives. In Nutrition and Dietary Interventions in Cancer (pp. 281–307). Springer Nature Switzerland. https://doi.org/10.1007/978-3-031-55622-7_11

David Stejskal | Nanobiotechnology | Best Researcher Award

Published on by Nano Technology

Prof. Dr. David Stejskal | Nanobiotechnology | Best Researcher Award

Professor, MD, PhD, MBA, EuSpLM, Head of the Institute of Laboratory Medicine | University Hospital in Ostrava | Czech Republic

Prof. Dr. David Stejskal, MD, PhD, MBA, EuSpLM, is a distinguished researcher and academic leader in the field of laboratory medicine, clinical biochemistry, and internal medicine. His research primarily focuses on the identification and clinical validation of novel biomarkers relevant to metabolic, cardiovascular, nephrological, and inflammatory diseases. With over 3,767 citations, an h-index of 29 (Scopus), and more than 200 peer-reviewed publications, his scholarly influence spans translational diagnostics and clinical applications in metabolic and endocrine disorders. His most cited works include pioneering studies on fatty acid binding proteins (FABP), chemerin, and FGF23, which have significantly advanced understanding of biomarkers in metabolic syndrome, chronic kidney disease, and cardiovascular risk assessment. Prof. Dr. David Stejskal’s research group has also contributed substantially to the development of novel diagnostic markers for diabetes, obesity, and atherosclerosis, as well as the evaluation of inflammatory and oxidative stress parameters in internal medicine. Beyond journal publications, he has authored and co-authored several scientific books such as Metabolic Diseases of Mass Incidence, Dyslipidemia, and Urolithiasis, alongside chapters in specialized medical encyclopedias. His work has been instrumental in shaping biomarker-based diagnostic strategies across Central Europe. Prof. Dr. David Stejskal has received notable research and organizational recognitions, including the OMICS Award (USA) for excellence in translational medicine and the Czech Society of Clinical Biochemistry Award. As an editorial contributor, reviewer, and conference organizer, he has significantly influenced international collaboration in laboratory and clinical research. His continued focus on biochemical innovation, diagnostic optimization, and translational research highlights his contribution to advancing laboratory medicine and evidence-based clinical diagnostics globally.

Profiles: Scopus | ORCID | ResearchGate | Sci Profiles | Web of Science

Featured Publications

1. Sigutova, R., Evin, L., Kusnierova, P., Svagera, Z., Branny, M., & Vaclavik, J. (2025). Specific microRNAs for heart failure: Reference values in whole blood. Biomedicines, 13(10), 2559. https://doi.org/10.3390/biomedicines13102559

2. Urinovska, R., Sistik, P., Buzga, M., & Stejskal, D. (2024). Fast and easy simultaneous determination of riboflavin, folic acid, all-trans-retinol and α-tocopherol in human serum by LC/MS/MS for bariatric patients. Journal of Chromatographic Science. https://doi.org/10.1093/chromsci/bmae035

3. Johannsen, B., Baumgartner, D., Karpíšek, M., Paust, N., Zengerle, R., & Mitsakakis, K. (2024). Integration of a bead-based immunoassay on a commercial PCR-performing POC device. Proceedings, 2024(097166). https://doi.org/10.3390/proceedings2024097166

4. Johannsen, B., Baumgartner, D., Karpíšek, M., Paust, N., Zengerle, R., & Mitsakakis, K. (2023). Patient stratification for antibiotic prescriptions based on the bound-free phase detection immunoassay of C-reactive protein in serum samples. Biosensors, 13(12), 1009. https://doi.org/10.3390/bios13121009

5. Plášek, J., Lazárová, M., Dodulík, J., Švagera, Z., Všianský, F., & Václavík, J. (2022). Secretoneurin as a novel biomarker of cardiovascular episodes: Are we there yet? A narrative review. Journal of Clinical Medicine, 11(23), 7191. https://doi.org/10.3390/jcm11237191

Prof. Dr. Salvatore De-Simone | Nanobiotechnology Awards | Best Researcher Award

Published on by Nano Technology

Prof. Dr. Salvatore De-Simone | Nanobiotechnology Awards | Best Researcher Award

Prof. Dr. Salvatore De-Simone ,Oswaldo Cruz Institute (IOC),Brazil

Salvatore Giovanni De Simone is a prominent biochemist with a distinguished career in the fields of biotechnology, molecular biology, and infectious diseases. He earned his Bachelor of Science in Biomedical Sciences from the State of Rio de Janeiro University (1976), followed by a Master’s (1980) and Doctorate (1986) in Biochemistry from the Federal University of Rio de Janeiro. Throughout his career, Dr. De Simone has held various prestigious positions, including Full Professor of Biochemistry at the Federal Fluminense University and Chief of the Biochemistry of Protein and Peptides Laboratory at the Oswaldo Cruz Institute (FIOCRUZ). He has also served as a visiting researcher at several renowned international institutions. Currently, Dr. De Simone is a Specialist in Science and Technology Production and Innovation in Health at the Oswaldo Cruz Foundation and a member of the National Institute of Neglected Population Diseases of Brazil. His research focuses on antimicrobial peptides, protein structure, and immunological diagnostics, and he has published extensively on these topics. Dr. De Simone has supervised numerous graduate students and postdoctoral researchers and has coordinated significant national and international research projects and symposiums.

Professional Profile:

Scopus

Orcid

Suitability for the “Best Researcher Award” – Summary and Conclusion

Candidate: Salvatore Giovanni De Simone

Summary of Suitability: Salvatore Giovanni De Simone is an accomplished scientist with an extensive background in biochemistry, molecular biology, and infectious diseases. His career spans over four decades, highlighted by significant contributions to academia, research, and scientific innovation. De Simone has held prestigious positions, including Full Professor of Biochemistry at the Federal Fluminense University and Chief of the Biochemistry of Protein and Peptides Laboratory at the Oswaldo Cruz Institute. His work has led to numerous advancements in understanding and combating infectious diseases, particularly through the study of protein structures, antimicrobial peptides, and the development of diagnostic tools.

🎓Education:

Salvatore Giovanni De Simone holds a Bachelor of Science in Biomedical Sciences from the State of Rio de Janeiro University, completed in 1976. He further advanced his education by earning a Master of Science in Biochemistry in 1980, followed by a Doctor of Science in Biochemistry in 1986, both from the Federal University of Rio de Janeiro

🏢Work Experience:

Salvatore Giovanni De Simone has held numerous prestigious positions throughout his career. He is currently a Specialist in Science and Technology Production and Innovation in Health at the Center for Technological Development in Health (CDTS) at the Oswaldo Cruz Foundation in Rio de Janeiro, Brazil. Previously, he served as a Full Professor of Biochemistry at the Federal Fluminense University in Niterói, Rio de Janeiro, from 1984 to 2012. He also led the Biochemistry of Protein and Peptides Laboratory at the Oswaldo Cruz Institute (FIOCRUZ) from 1992 to 2012. In addition to his roles in Brazil, Dr. De Simone has gained international experience as a Visiting Researcher at the Laboratory of Genic Recombination at the Institut d’Hematologie-Centre Hayem, Hopital St. Louis in Paris, France, in 1987; at the Department of Medical Parasitology at New York University (NYU) in the United States from 1988 to 1989; and at the European Molecular Biology Laboratory (EMBL) in Germany in 1990.

🏅Awards and Honors:

Salvatore Giovanni De Simone has been recognized with several notable awards and positions throughout his career. He has received the Researcher Productivity Award (Category 1C) from the National Council of Scientific and Technological Development (CNPq) in Brazil and has been honored as a Scientist of the State of Rio de Janeiro by the Foundation for Research Support of the State of Rio de Janeiro (FAPERJ). Dr. De Simone also coordinated the Peptide Synthesis Platform at the Oswaldo Cruz Foundation from 1992 to 2012. Additionally, he served as a member of the Assessment Committee in Biotechnology for the National Council of Research from Brazil (CNPq) during the 2022-2023 term.

Publication Top Notes:

  • Title: Development of an Electrochemical Immunosensor for the Diagnostic Testing of Spotted Fever Using Synthetic Peptides
    • Citations: 18
  • Title: Cryptosporidium spp. Contamination in Perna perna Mussels Destined for Human Consumption in Southeastern Rio de Janeiro, Brazil
    • Citations: 7
  • Title: Ultrasensitive and Rapid Immuno-detection of Human IgE Anti-therapeutic Horse Sera Using an Electrochemical Immunosensor
    • Citations: 9
  • Title: Development of an ELISA for the Diagnosis of Reactive IgE Antibodies Anti-therapeutic Horse Sera
    • Citations: 10
  • Title: Oligopeptidase B and B2: Comparative Modelling and Virtual Screening as Searching Tools for New Antileishmanial Compounds
    • Citations: 11